Rhenman & Partners Asset Management AB
$1.1B 13F equity value
106 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Rhenman & Partners Asset Management AB covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| UNH | UNITED HEALTH GROUP INC | 93,600 | $39M | 3.7% |
| CVS | CVS HEALTH CORP | 279,374 | $29M | 2.7% |
| AZN | ASTRAZENECA PLC | 151,500 | $28M | 2.7% |
| MRK | MERCK & CO INC | 213,500 | $27M | 2.6% |
| LLY | LILLY ELI & CO | 22,315 | $27M | 2.5% |
| ABBV | ABBVIE INC | 96,775 | $24M | 2.3% |
| ALHC | ALIGNMENT HEALTHCARE INC | 997,083 | $24M | 2.2% |
| EW | EDWARDS LIFESCIENCES CORP | 260,000 | $24M | 2.2% |
| GILD | GILEAD SCIENCES INC | 178,250 | $23M | 2.1% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 87,440 | $21M | 2.0% |
Track Rhenman & Partners Asset Management AB's 13F portfolio: $1.1B in reported holdings, 106 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}